Virus-like particles (VLPs) are multiprotein structures that mimic the organization and
conformation of authentic native viruses but lack the viral genome, potentially yielding safer …

Virus-like particles (VLPs) hold tremendous potential as vaccine candidates. These
innovative biopharmaceuticals present the remarkable advantages of closely mimicking the …

Virus-like particles (VLPs) are multiprotein structures that resemble the conformation of
native viruses but lack a viral genome, potentiating their application as safer and cheaper …

The baculovirus expression vector system (BEVS) is a versatile and powerful platform for
protein expression in insect cells. With the ability to approach similar post-translational …

The insect cells/baculovirus system is well recognized as a safe and suitable technology to
produce heterologous proteins, vaccines and vectors for gene therapy. Efficient and robust …

The success of baculovirus/insect cells system in heterologous protein expression depends
on the robustness and efficiency of the production workflow. It is essential that process …

Virus-like particles (VLP) are formed when viral structural proteins are produced in an
heterologous expression system. Such proteins assemble into structures that are …

Insect cells can be used for the efficient production of heterologous proteins. The
baculovirus expression vector system (BEVS) in Spodoptera frugiperda cells and the stable …

Although viruses are simple biological systems, they are capable of evolving highly efficient
techniques for infecting cells, expressing their genomes, and generating new copies of …

Recombinant baculoviruses (rBac) are used for many different applications, ranging from bio-
insecticides to the production of heterologous proteins, high-throughput screening of gene …